1. Early treatment of Campylobacter jejuni enteritis.
- Author
-
Williams MD, Schorling JB, Barrett LJ, Dudley SM, Orgel I, Koch WC, Shields DS, Thorson SM, Lohr JA, and Guerrant RL
- Subjects
- Adult, Campylobacter Infections microbiology, Campylobacter fetus drug effects, Child, Drug Combinations pharmacology, Drug Combinations therapeutic use, Enteritis microbiology, Erythromycin pharmacology, Feces microbiology, Female, Humans, Male, Microbial Sensitivity Tests, Sulfamethoxazole pharmacology, Time Factors, Trimethoprim pharmacology, Trimethoprim, Sulfamethoxazole Drug Combination, Campylobacter Infections drug therapy, Enteritis drug therapy, Erythromycin therapeutic use, Sulfamethoxazole therapeutic use, Trimethoprim therapeutic use
- Abstract
The bacteriologic and clinical effects of early antibiotic treatment of Campylobacter jejuni enteritis were studied. Erythromycin rapidly eliminated C. jejuni from stools, whereas trimethoprim-sulfamethoxazole did not. Despite its bacteriologic effectiveness, erythromycin did not reduce the duration or severity of diarrhea, abdominal pain, or other symptoms.
- Published
- 1989
- Full Text
- View/download PDF